Lemonade Inc. (LMND)
44th Anniversary Buy-and-Hold Pick: Lemonade (LMND)
Schaeffer's Investment Research turns 44 this month!
Are Finance Stocks Lagging Lemonade (LMND) This Year?
Here is how Lemonade (LMND) and Acadian Asset Management (AAMI) have performed compared to their sector so far this year.
Lemonade: 2026 Will Be A Huge Year
The S&P 500's high valuations make me more selective, and Lemonade stands out as a high-conviction pick. Lemonade recently surpassed $1B in in-force premiums, demonstrating impressive growth just a decade after its founding. The stock is up 63% since my last 'Strong Buy' rating, but I see significant upside remaining, especially after the reinsurance changes.
Lemonade (LMND) Moves 9.4% Higher: Will This Strength Last?
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Lemonade: The AI Advantage That Could Tip The Scales
Lemonade's Q1 2025 results show accelerating growth, improving margins, and strong cash reserves, validating its AI-driven scaling thesis. The company's proprietary AI stack powers rapid underwriting and claims, compounding data advantages and driving operating leverage as policyholder cohorts mature. Risks include catastrophe volatility, regulatory delays, and competitive pressure, but Lemonade's balance sheet and data moat offer resilience.
5 Stocks I Am Most Bullish On Today
Lemonade (LMND) is a top AI-driven insurance disruptor, with significant long-term upside as it scales and leverages operating efficiencies. Amazon (AMZN) remains deeply undervalued, with AWS and advertising segments alone justifying a higher valuation than its current market cap. Nebius (NBIS) is poised for substantial growth, with ARR and capacity expansion supporting a conservative 4.5x upside from current levels.
Lemonade: Fundamentals Set To Accelerate After Q1 Hiccup
IFP growth accelerated for the sixth straight quarter, and it is likely to accelerate further for the remainder of the year. Despite a slight downswing in Q1, profitability is expected to accelerate in Q2 and beyond. About 30% of Lemonade's float is sold short.
Lemonade: The Future Of Insurance Is Still Trading At Early-Stage Levels
Now is an ideal time to invest in small-cap stocks like Lemonade, with the market largely overlooking its expansive growth rates. In Q1, Lemonade accelerated premium growth for the sixth straight quarter, while also keeping loss ratios steady despite the impacts of the LA wildfires in January. Lemonade's innovative use of AI to automate policy claims and economies of scale on marketing are driving it towards adjusted EBITDA breakeven by FY26.
Lemonade Delivers Sweet Results, Price Reversal to Accelerate
The Q1 results and guidance affirmed the outlook and included a pathway to profits. It will still take some time, but the company is on track to reach EBITDA break-even by the end of 2026.
Lemonade, Inc. (LMND) Q1 2025 Earnings Call Transcript
Lemonade, Inc. (NYSE:LMND ) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET Company Participants Natalie Wilson - Director of Communications Daniel Schreiber - Co-Founder, Chief Executive Officer and Chairman Michal Langer - Chief Product Officer Tim Bixby - Chief Financial Officer Conference Call Participants Jack Matten - BMO Jason Helfstein - Oppenheimer Bob Huang - Morgan Stanley Andrew Kligerman - TD Securities Katie Sakys - Autonomous Research Tommy McJoynt - KBW Operator Hello, and welcome, everyone to the Lemonade Q1 2025 Earnings Call. My name is Maxine, and I'll be coordinating the call today.
Lemonade (LMND) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Lemonade (LMND) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Lemonade (LMND) Reports Q1 Loss, Tops Revenue Estimates
Lemonade (LMND) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $0.94. This compares to loss of $0.67 per share a year ago.
